AlloMend Acellular Dermal Matrix Allograft in Pre-Pectoral Breast Reconstruction

Description

This is a single-center, retrospective study which will be used to describe and evaluate the effectiveness of AlloMend® Acellular Dermal Matrix allograft for patients that have undergone Pre-Pectoral Breast Reconstruction surgery following a single or double mastectomy.

Conditions

Pre-Pectoral Breast Reconstruction Following Single or Double Mastectomy

Talk to us

Study Overview

On this page

Study Details

Study overview

This is a single-center, retrospective study which will be used to describe and evaluate the effectiveness of AlloMend® Acellular Dermal Matrix allograft for patients that have undergone Pre-Pectoral Breast Reconstruction surgery following a single or double mastectomy.

A Retrospective Study To Evaluate The Safety And Effectiveness Of AlloMend® Acellular Dermal Matrix Used In Post Mastectomy Pre-Pectoral Breast Reconstruction And Followed For Up To 6-Months Post-Operatively.

AlloMend Acellular Dermal Matrix Allograft in Pre-Pectoral Breast Reconstruction

Condition
Pre-Pectoral Breast Reconstruction Following Single or Double Mastectomy
Intervention / Treatment

-

Contacts and Locations

Joliet

Alan H. Chen Surgical Associates, PC, Joliet, Illinois, United States, 60435

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Diagnosed by a physician and required a single or double mastectomy followed by Pre-Pectoral Breast Reconstruction surgery with the use of AlloMend® Acellular Dermal Matrix allograft;
  • * Surgical intervention using AlloMend® Acellular Dermal Matrix allograft was used;
  • * Has completed or will complete the anticipated clinically indicated follow-up visits at 2 weeks, 6 weeks, 3 months, and 6 months post-surgical intervention.
  • * Did not utilize AlloMend® Acellular Dermal Matrix allograft during pre-pectoral breast reconstruction
  • * Did not have post-operative evaluations at the clinical site.

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

FEMALE

Accepts Healthy Volunteers

No

Collaborators and Investigators

AlloSource,

Study Record Dates

2024-12-31